Shopping for care: New healthcare tool aims to further price transparency

Amino, a health data company, launched a new tool that allows healthcare consumers access to expanded pricing data, based on physician, procedure and insurance company, according to a USA Today report.

Advertisement

Here are five key notes:

1. The information is based on billions of medical insurance claims.

2. The tool’s data covers 550,000 physicians, 49 procedures and 129 insurance companies.

3. In the push toward price transparency, Amino’s tool is an “important first step,” noted Neel Shah, MD, founder of Costs of Care, a nonprofit.

4. While Amino aims to give users as accurate a picture as possible regarding healthcare costs, its estimates can vary widely.

5. Amino CEO and Co-Founder David Vivero says that “the goal is to give [users] ‘a leg up’ when they visit their doctor’s office,” according to the report.

More articles on ASC issues:
$900M Medicare funding boost to enhance preventive medicine in 2017: 5 things to know
AMA, BCBS & Trinity Health continue ongoing battle to delay MACRA — 5 things to know
GOP investigation claims Obama administration made ACA payments illegally: 6 highlights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Coding, Billing & Collections

Advertisement

Comments are closed.